Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN ) is a leading biotechnology company based in Tarrytown, New York. REGN develops therapies for eye diseases, cancer, allergic conditions, and infectious diseases. Its portfolio contains commercial Eylea, Dupixent, and Libtayo that address critical medical needs andMy name is Myriam Hernandez Alvarez. I received the Electronics and Telecommunication Engineering degree from the Escuela Politecnica Nacional, Quito, Ecuador, the M.Sc. degree in computer science from ...